@prefix n9j: <http://data.loterre.fr/ark:/67375/N9J> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix isothes: <http://purl.org/iso25964/skos-thes#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

n9j:-X53K2K0F-1
  skos:prefLabel "treatment theories, research, techniques, strategies, and effectiveness"@en ;
  a skos:Concept ;
  skos:narrower n9j:-TN6RZK11-K .

n9j: a skos:ConceptScheme .
n9j:-MB48CG9B-5
  skos:prefLabel "drug classification"@en ;
  a skos:Concept ;
  skos:narrower n9j:-TN6RZK11-K .

n9j:-concepts
  a isothes:ConceptGroup ;
  skos:prefLabel "concepts"@en ;
  skos:member n9j:-TN6RZK11-K .

n9j:-TN6RZK11-K
  owl:sameAs <https://concepts.sagepub.com/social-science/concept/buprenorphine> ;
  skos:definition "Buprenorphine is a medication to treat opioid dependence. It was approved by the U.S. Food and Drug Administration on October 8, 2002, as a Schedule III narcotic (i.e., it has abuse potential and it is used as a medicine in the United States). [Source: Encyclopedia of Substance Abuse Prevention, Treatment, & Recovery; Buprenorphine]"@en ;
  a skos:Concept ;
  skos:inScheme n9j: ;
  skos:broader n9j:-X53K2K0F-1, n9j:-MB48CG9B-5 ;
  skos:prefLabel "buprenorphine"@en .